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Cytokine-producing CD4 T cells have important roles in immunity against Plasmodium 
falciparum (Pf) malaria. However, the factors influencing functional differentiation of
Pf-specific CD4 T cells in naturally exposed children are not well understood. Moreover, 
it is not known which CD4 T-cell cytokine-producing subsets are most critical for protec-
tion. We measured Pf-specific IFNγ-, IL10-, and TNFα-producing CD4 T-cell responses 
by multi-parametric flow cytometry in 265 children aged 6 months to 10 years enrolled 
in a longitudinal observational cohort in a high malaria transmission site in Uganda. We 
found that both age and parasite burden were independently associated with cytokine 
production by CD4 T cells. IL10 production by IFNγ+ CD4 T cells was higher in younger 
children and in those with high-parasite burden during recent infection. To investigate the 
role of CD4 T cells in immunity to malaria, we measured associations of Pf-specific CD4 
cytokine-producing cells with the prospective risk of Pf infection and clinical malaria, 
adjusting for household exposure to Pf-infected mosquitos. Overall, the prospective risk 
of infection was not associated with the total frequency of Pf-specific CD4 T cells, nor 
of any cytokine-producing CD4 subset. However, the frequency of CD4 cells producing 
IL10 but not inflammatory cytokines (IFNγ and TNFα) was associated with a decreased 
risk of clinical malaria once infected. These data suggest that functional polarization of 
the CD4 T-cell response may modulate the clinical manifestations of malaria and play a 
role in naturally acquired immunity.
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inTrODUcTiOn
Despite a decline in the incidence of malaria globally, over 50% of the world’s population remains 
at risk of infection (1), with the largest burden caused by Plasmodium falciparum (Pf) parasites. 
Our incomplete understanding of the mechanisms mediating naturally acquired immunity to 
Pf poses a barrier to the development of vaccines and other control strategies. In endemic settings, 
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the incidence of symptomatic malaria declines with increasing 
age and cumulative exposure. However, even highly exposed 
individuals remain susceptible to asymptomatic Pf infection into 
adulthood, and adults do not differ in time-to-infection com-
pared with children, indicating that sterile immunity does not 
usually develop in response to natural infection (2). It is likely that 
the biological mechanisms underlying protection from infection 
and restriction of parasite growth are distinct from those that 
mediate protection from symptomatic malaria.
CD4 T-cell responses are important components of 
naturally acquired and vaccine-induced immunity to malaria 
[reviewed in Ref. (3)]. However, many aspects of the Pf-specific 
CD4 T-cell response in naturally exposed individuals, includ-
ing the critical effector functions responsible for preventing 
infection and clinical malaria, remain poorly understood. 
There has been a considerable body of research assessing the 
role of cytokines in protection or risk of malaria, which has 
highlighted a role for several cytokines including interferon 
gamma (IFNγ), interleukin 10 (IL10), and tumor necrosis 
factor alpha (TNFα) in anti-malarial immunity [reviewed in 
Ref. (4–6)]. However, these studies have largely been based on 
plasma cytokine measurements or, alternatively, measurement 
of cytokine production by bulk cell populations (e.g., ELISA 
of culture supernatants), and have therefore been unable to 
characterize the cytokines (or combinations of cytokines) that 
are produced at the individual cell level, or to phenotype the 
cell producing the cytokines (i.e., CD4 vs. CD8 T  cells, vs. 
others, such as γδ T cells). This is of fundamental importance 
because antigen-specific T cells are functionally heterogeneous, 
and the functional polarization of CD4 T cells, as defined by 
their cytokine production profiles, has been associated with 
the ability––or failure––to prevent or contain infection in 
several infectious disease models. In the few published studies 
which have used multicolor flow cytometry to assess Pf-specific 
cytokine production by CD4 T cells at an individual cell level, 
it has been shown that the Pf-specific CD4 T-cell response in 
highly malaria-exposed children is dominated by IFNγ and 
IL10 coproducing cells (7–10). Interleukin 10 production by 
CD4 T cells may help to control immunopathology and limit 
symptoms of infection (10), as suggested by murine models 
of malaria and other parasitic infections such as Leishmania 
and toxoplasmosis, where IL10 production from T helper cell 
(Th1) IFNγ-producing CD4 T cells is essential for dampening 
inflammatory responses, preventing disease (5, 11, 12), and 
protecting from IFNγ-dependent, TNFα-mediated pathology 
(13). CD4 T-cell responses may also be important in mediating 
protection from malaria by preventing parasite infection or 
restricting parasite replication once infection is established. 
We have recently shown that in areas of high malaria transmis-
sion, inflammatory CD4 T  cells producing IFNγ and TNFα 
dominate in immune adults, who rarely experience high-
density infections or clinical malaria despite constant exposure 
to infection (9).
Here, we studied a large and well-characterized longitudinal 
cohort of children from a highly malaria-endemic region of 
Eastern Uganda (14). We quantified Pf-specific IFNγ-, IL10-, 
and TNFα-producing CD4 T  cells from 265 children aged 
6 months to 10 years, and identified factors that influence the 
functional differentiation of Pf-specific CD4 T  cells. Then, 
using detailed clinical outcome measures and household-level 
mosquito data to control for heterogeneity in environmental 
exposure to infected mosquitos (15), we analyzed the relation-
ship between these CD4 subsets and prospective protection 
from Pf infection, and (separately) risk of developing clinical 
malaria once infected. Our data suggest opposing roles for 
TNFα and IL10 Pf-specific CD4 T cells in naturally acquired 
immunity to malaria in children.
MaTerials anD MeThODs
ethics statement
This study was carried out in accordance with the recommen-
dations of Uganda National Council of Science and Technology 
and the institutional review boards of the University of 
California, San Francisco, and Makerere University, with writ-
ten informed consent from all adult subjects or parent/guardian 
of all study participants. All subjects gave written informed 
consent in accordance with the Declaration of Helsinki.
The protocol was approved by the institutional review boards 
of the University of California, San Francisco (institutional 
review board number 11-05995; reference number 067647), and 
Makerere University.
study Participants
Samples were obtained from participants in the East African 
International Centers of Excellence in Malaria Research 
“PRISM” Nagongera study cohort that was initiated in 2011 
and is ongoing (14). This cohort consists of 100 households 
within the Nagongera sub-county in Tororo district. Malaria 
transmission in this region is holoendemic, with slight increases 
in malaria incidence and parasite prevalence during two annual 
seasonal peaks from October to January and April to July. 
In all households, one adult caregiver and all eligible children 
aged 6 months to 10 years were enrolled in the study. Exclusion 
criteria included any known chronic medical conditions requir-
ing specialized care (including HIV infection). The cohort is 
dynamic, with children exiting the study at age 11, and new 
children born into study households enrolled at 6 months of age. 
For the work presented here, all children were scheduled for an 
“immunology blood draw” with samples taken between January 
and April 2013. Children who presented with malaria (currently 
febrile and blood smear detectible parasites), or had a recorded 
episode of malaria in the last 7 days, were re-scheduled to be bled 
at a later time point. In total, plasma blood mononuclear cell 
(PBMC) responses from 265 out of 270 children enrolled at the 
time of sampling were collected and analyzed. The study cohort 
characteristics of sampled children are presented in Table 1.
clinical Management and Measurement  
of clinical Parameters
Upon enrollment all study participants were given an insecticide 
treated bed net and followed for all medical care at a dedicated 
study clinic. All participants were reimbursed for travel to and 
Table 1 | Study cohort characteristics.
characteristic Finding
Number of children 265
Age, years (median, IQR) 5.8 (3.5–8.1) 
Patent infection at blood draw (blood smear positive) 77 (29%)
Subpatent infection at blood draw (PCR positive,  
smear negative)
29 (11%)
Any infection at blood draw (blood smear  
and/or PCR positive)a
106 (40%)
Clinical characteristics in the year prior to blood draw
Person-days observed (median, min–max) 365 (36–365)
Malaria incidence (median, IQR) 2.0 (1.0–4.0)
Parasite density during infection in last 3 months  
(log10, parasite/μL, median, IQR)b
3.9 (3.3–4.6)
Characteristics in the year following blood draw
Number of routine visits/childc (median, min–max) 4 (0–5)
Odds of any infection at routine visitd (OR, 95% CI) 4.8 (3.6–6.5)
Odds of malaria at routine visit (OR, 95% CI) 0.26 (0.21–0.33)
dMER in year following blood draw, female Anopheles/ 
house/day (median IQR)e
27.3 (16.5–37.1)
aCurrent infection measured by PCR from dried blood spots and/or blood smear,  
all infections are asymptomatic.
bParasite density is the most recent patent, blood smear positive parasite infection 
within the last 3 months, log transformed. In total, 211 children had a patent infection  
in 3 months prior to blood draw.
cFor protection analysis, all routine visits were considered. Routine visit was 
characterized as no-infection, low-density infection (LAMP positive, blood smear 
negative), patent infection (blood smear positive), or malaria (blood smear positive and 
fever at visit, or within 21 days prior and 7 days following visit). Odds of infection were 
calculated with mixed-effects logistic regression.
dOdds of any infection at routine includes symptomatic malaria infection cases, and 
asymptomatic patent (blood smear detectable) or asymptomatic subpatent (blood 
smear negative, LAMP positive).
edMER is estimated from the mean household CDC light trap counts of Anopheles 
mosquito measured at monthly intervals over the 12 months following blood draw.
dMER, daily mosquito exposure rate; LAMP, loop-mediated isothermal amplification; 
PCR, polymerase chain reaction.
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from clinic for all visits, increasing the likelihood that all cases 
of malaria infection were detected. Furthermore, participants 
agreed to avoid all antimalarial medications administered 
outside the study, and compliance was tracked with question-
naire at all routine study visits. Children who presented with 
a fever (tympanic temperature ≥38.0°C) or history of fever in 
the previous 24 h had blood obtained by finger prick for a thick 
smear. If the thick smear was positive for Plasmodium parasites, 
the patient was diagnosed with malaria regardless of parasite 
density, and treated with artemether–lumefantrine, the recom-
mended treatment for malaria in Uganda. Incident episodes of 
malaria were defined as all febrile episodes accompanied by any 
parasitemia requiring treatment, but not preceded by another 
treatment in the prior 14 days.
Routine assessments with active case detection were per-
formed in the study clinic every 3  months, including blood 
smears and dry blood spots to detect for parasite infection. 
Negative blood smears obtained at routine assessments were 
tested for the presence of submicroscopic malaria parasites using 
loop-mediated isothermal amplification (LAMP) (16). At the 
time of routine assessments, children were divided into four cat-
egories: (1) no evidence of parasite infection; (2) asymptomatic, 
submicroscopic (LAMP positive) infection; (3) asymptomatic, 
blood smear positive infection, or (4) symptomatic malaria, with 
a window of 21 days prior to and 7 days following the routine 
visit to ensure capture of malaria episodes that were recently 
treated or infections that soon became symptomatic.
To assess for submicroscopic infection at the time of the 
“immunology” blood draw, Plasmodium DNA was extracted 
from dried blood spots and analyzed by polymerase chain reac-
tion (PCR) as previously described (17). In 17 children (6.3%), 
PCR was not performed due to missing dried blood spots 
and current infection status was imputed from blood smear 
(10 were positive by blood smear, and 7 were negative). 
All analysis considered infection status as positive if participant 
had either a blood smear patent infection, or a PCR positive, 
blood smear negative subpatent infection.
Daily Mosquito exposure rate (dMer)
The dMER was calculated for each individual based on the mean 
household-level female Anopheles mosquito counts obtained 
from CDC light traps placed overnight (once per month) 
within the household of each individual trial participant (15). 
For analyses to assess drivers of CD4 T-cell responses, dMER 
was calculated as the mean female Anopheles mosquito counts 
from the prior 12 months, and for analyses to assess outcomes of 
protection, dMER was calculated as the mean female Anopheles 
mosquito counts from the 12  months following blood draw. 
dMER was used in analysis as a categorical variable (0–8, >8–40, 
>40–80, and >80 mosquitos/household/day), based on analy-
ses of the relationship between dMER and infection (Table S1 
in Supplementary Material).
Measuring Pf cD4 T-cell responses
Analysis of CD4 T-cell responses to Pf-infected red blood 
cells (RBCs) via intracellular cytokine staining was performed 
as previously described (8, 9). PBMCs were stimulated with 
Pf-infected RBCs or uninfected RBCs and CD4 T-cell produc-
tion of IFNγ, IL10, and TNFα were measured via intracellular 
staining. PBMCs were thawed using standard methods and 
rested overnight in 10% fetal bovine serum. A total of 106 PBMCs 
were stimulated with intact purified trophozoite/schizont-stage 
Pf (clone 3D7)-infected RBCs or uninfected RBCs at an effector 
to target ratio of 1:2. Parasite cultures were routinely confirmed 
mycoplasma negative. Following 6  h of stimulation, Brefeldin 
A and monensin (BD Pharmingen) were added (10  µg/mL). 
At 24 h, cells were washed, and surface and intracellular stain-
ing was performed with the following antibodies: from BD 
Pharmingen, anti-CD3-PerCP (SK7), anti-CD8-APC-H7 (SK1), 
anti-IFNγ-PE-Cy7 (B27), anti-IL-10-PE (JES3-19F1), and anti-
TNFα-FITC (6401.1111); from Biolegend, anti-CD4-BV650 
(OKT4), anti-CD14-Alexa700 (M5E2), anti-CD19-Alexa700 
(HIB19), and anti-T-Bet BV421 (4B10); from Milteny anti-γδVδ2-
APC (123R3); from R&D anti-BLIMP-1 Alexa647 (646702); and 
from Invitrogen, Live/Dead aqua amine. Samples were acquired 
on a BD LSR2 flow cytometer with FACSDiva. A median of 
121,000 CD4 T  cells were collected (IQR 98,310–144,000, 
minimum 10,000, maximum 197,000).
Flow cytometry data were analyzed using FlowJo software 
(Tree Star, San Carlos, CA, USA) and Pestle (version 1.7)/Spice 
(version 5.3; M. Roederer, Vaccine Research Center, National 
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Institute of Allergy and Infectious Diseases, National Institute of 
Health available at: http://exon.niaid.nih.gov (18). Color com-
pensation was performed using single-color cell controls or beads 
stained for each fluorochrome. Responding cells were gated as 
lymphocytes/singlets/CD14−CD19−Aqua−/CD3+ γδVδ2−/CD8−/ 
CD4+. Cytokine production was gated as CD4 producing IFNγ, 
IL-10, or TNFα, and Boolean gating was performed to categorize 
cells into subsets (Figure S1 in Supplementary Material). To 
calculate frequencies of Pf -specific CD4 T  cells, background 
responses to uninfected RBCs were subtracted from each subset 
(Figure S2 in Supplementary Material). For data analysis, IFNγ+/
IL10+/TNFα+ and IFNγ+/IL10+/TNFα+ responses were com-
bined. Data were analyzed as the frequency of each subset as % 
of total CD4 T cells. To assess the composition of the Pf-specific 
response, total IFNγ, IL10, or TNFα frequencies or specific 
subsets as enumerated via Boolean gating were divided by the 
frequency of total responding CD4+ T  cells and multiplied by 
100 to calculate the % of total response.
statistical Data analysis
All statistical methods were performed using Prism 4 (Graph-
Pad), STATA version 12 (College Station), or SPICE v.5.3 version 
5.3; M. Roederer, Vaccine Research Center, National Institute 
of Allergy and Infectious Diseases, National Institute of Health 
available at: http://exon.niaid.nih.gov) (18). Associations between 
dMER and age with probability of infection were calculated 
using Spearman’s correlations and linear regression analysis. 
To assess relationships between age and dMER with retrospec-
tive odds of infection measured at quarterly routine assessments, 
the odds of any infection (defined as either LAMP positive or 
blood smear positive with or without symptoms) were calculated 
using multilevel mixed-effects logistic regression, accounting for 
repeat measures within individuals and clustered on household 
to account for multiple children in each individual household.
For CD4 T-cell responses, frequencies and proportions of 
responses were compared with Wilcoxon rank sum for binary 
variables, Kruskal–Wallis for group variables (age groups: 0–3, 
>3–7, >7 years), and via Spearman’s rank correlation for con-
tinuous variables. For multivariate analysis, associations were 
made via linear regression, with the frequencies of CD4 T-cell 
responses log transformed, and predictor variables age (linear), 
current PCR positive infection (dichotomous), and dMER 
(categorical 0–8, >8–40, >40–80, >80 female Anopheles/house/
day) assessed cocurrently where indicated. To assess parasite 
antigen burden during infection in the 3  months prior to the 
immunology blood draw, parasite density (log transformed) was 
calculated from blood-smear of most recent infection.
To assess relationships between cross-sectional CD4 T-cell 
responses and the prospective odds of infection measured at 
repeated, quarterly routine assessments, the odds of any infection 
(defined as either LAMP positive or blood smear positive with 
or without symptoms) and the odds of symptoms when patent 
infected (defined as malaria when patent blood smear infection 
detected) were calculated using multilevel mixed-effects logistic 
regression, accounting for repeat measures within individuals 
and clustered on household to account for multiple children in 
each individual household. In multivariate analysis, odds ratios 
for infection risk were adjusted for age (linear), dMER (categori-
cal 0–8, >8–40, >40–80, >80 mosquitos/household/day) and 
PCR positive infection at blood draw.
To assess relationships between CD4 T-cell responses and 
parasite burden during asymptomatic infection, the geometric 
mean parasite burden across all detected infections (LAMP 
positive and blood smear positive) during routine visits was 
calculated. Associations with CD4 T-cell response were assessed 
with multivariant logistical regression controlling for age and 
infection status at time of sampling.
resUlTs
study cohort and clinical Outcomes
We performed a cross-sectional study of 265 children (aged 
6 months to 10 years) enrolled in a longitudinal observational 
cohort in Nagongera, Uganda (Table  1) (14). This region has 
very high Pf malaria transmission, with an estimated annual 
entomological inoculation rate (aEIR) of 310 bites per person 
year (15). The malaria epidemiology of this cohort has previ-
ously been described (14). Briefly, parasite prevalence is high, 
increasing from 0.15 at 6  months to >0.3 by 4  years of age. 
Malaria incidence peaks at approximately four cases/year at 
age 3, and then declines (Table 1; Figure S3A in Supplementary 
Material). Consistent with these prior results, at the time of sam-
pling 29% (n = 77) of children in our study had asymptomatic 
Pf infection detectable by blood smear (“patent” infection), 
and an additional 11% (n  =  29) had subpatent Pf infection 
detectable by PCR. Thus, in total, 40% (n = 106) of our study 
population had asymptomatic infection (patent or subpatent) 
at time of sampling. Eighty percent (n = 211) of children had 
a blood smear positive parasite infection in the 3 months prior 
to sampling, at which the median log10 parasite density was 
3.9  parasites/μL, IQR 3.3–4.6. Parasite density during recent 
infection correlated inversely with age (rho = –0.52, p < 0.0001, 
Figure S3B in Supplementary Material).
Blood was drawn for immunological analysis at a single cross-
sectional time point, after which children were followed for 
1 year, and the odds of parasite infection (patent and subpatent) 
and symptomatic malaria were assessed during quarterly clinic 
visits (Table  1). Increasing age was associated with increased 
odds of any infection (subpatent LAMP positive or patent 
blood smear positive with or without symptoms, OR 1.17, 95% 
1.08–1.27, p < 0.001, Table S1 in Supplementary Material), con-
sistent with prior reports in this cohort (14). For every increased 
year of age, there was a 15% reduced odds of malaria (OR 0.85, 
95% CI 0.80–0.92 p  <  0.001), consistent with the gradual 
devel opment of clinical immunity. In order to control for the 
confounding factor of heterogeneity in exposure to Plasmodium 
transmission vectors in protection analyses, household mosquito 
counts were used to calculate an individual dMER in the year 
following blood draw (median 27.3 IQR 16.5–37.1 Anopheles/
house/day, Figure S3C in Supplementary Material). After con-
trolling for age and clustering by household, dMER was strongly 
associated with an increased odds of infection in the year follow-
ing blood draw (OR 7.6, p = 0.007 for dMER > 80 compared with 
FigUre 1 | Frequency of Pf CD4 T-cell response reduced during asymptomatic infection. (a) Pf-specific CD4 T cells producing IFNγ, IL10, and TNFα were 
measured in 265 children via flow cytometry following incubation of PBMCs with parasite-infected RBCs. Responses were analyzed by Boolean gating in SPICE.  
(b) The proportion of CD4 T cells producing each cytokine combination was calculated as the percentage of the total parasite-specific CD4 T cells. A pie graph 
depicting the average proportion of these subsets among all children was generated in SPICE [pie slice colors correspond to the squares at the bottom of  
(a)]. Mean proportion of each response is indicated. (c,D) Current infection with P. falciparum was assessed via PCR. In currently infected children (n = 106),  
the total frequency of cytokine-producing CD4 T cells and IFNγ-, IL10-, and TNFα-producing CD4 T cells were all reduced compared with uninfected children 
(n = 159). Median and IQR are indicated by black bar and whiskers, with p-values for Wilcoxon rank sum test. IFNγ, interferon gamma; IL10, interleukin 10;  
PBMCs, plasma blood mononuclear cells; PCR, polymerase chain reaction; RBCs, red blood cells; TNFα, tumor necrosis factor alpha.
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dMER 0- < 8, Table S1 in Supplementary Material), suggesting 
that this measure was able to account for some heterogeneity 
of exposure within the cohort.
asymptomatic Parasitemia associated 
With a lower Frequency of circulating 
Pf-specific cD4 T cells
Plasmodium falciparum-specific CD4 T-cell production of 
IFNγ, IL10, and TNFα was measured by flow cytometry follow-
ing stimulation of PBMCs with Pf-infected RBCs. Responding 
cells were analyzed as the frequency of total CD4 T  cells. 
All individuals exhibited a measurable CD4 T-cell response to 
malaria, and among cytokine-producing CD4 T cells, on aver-
age 58% were monofunctional (produced a single cytokine), 
36% coproduced two cytokines, and 4% coproduced all three 
cytokines. CD4 T cells producing IFNγ, IL10, or both, domi-
nated the response (Figures  1A,B), consistent with previous 
observations (7–9). In children with asymptomatic infection 
(patent or subpatent) at time of blood draw, we observed a 
lower frequency of total Pf-specific CD4 T cells (Figure 1C), 
and of CD4 T cells producing any of the three cytokines (IFNγ, 
IL10, and TNFα), as well as all multi-cytokine-producing com-
binations defined by Boolean gating (Figure 1D; Figure S4A in 
Supplementary Material). The lower frequency of Pf-specific 
CD4 T cells among parasitemic children remained significant 
in multivariate analysis after controlling for both household 
levels of mosquito exposure (dMER) and age (Table S2 in 
Supplementary Material). There was no difference in the fre-
quency of total CD4 T cells, as a percent of CD3 T cells (p = 0.51, 
FigUre 2 | IFNγ in the absence of IL10 increasing with age and 
decreasing with IFNγ/IL10 coproduction. (a) The frequencies of total CD4 
T cells producing IFNγ, IL10, or TNFα were compared between children 
aged 0 and 3 years (n = 46), >3–7 (n = 121), and >7–11 (n = 98). There 
was no difference in the frequencies of responding cells between age 
groups. Kruskal–Wallis comparisons across age groups for each cytokine 
are indicated. (b) The frequencies of CD4 T cells producing subsets of 
cytokines were analyzed by Boolean gating. IFNγ+/IL10− with or without 
TNFα (IFNγ+/IL10−/TNFα−, and IFNγ+/IL10−/TNFα+) and IFNγ+/IL10+ with or 
without TNFα (IFNγ+/IL10+/TNFα−, and IFNγ+/IL10+/TNFα+) are collapsed 
for simplicity. Data are the lowess smoothed data with age, Spearman’s is 
for IFNγ+/IL10− responses. (c) The proportion of the total IFNγ response 
that was coproducing IL10 was calculated as follows: 
% γ ( αCD4Tcells producing IFN and  IL10 with  or without TNF )
% γ( )CD4Tcell  producing  IFN alone  or in combination
. Rho and p for 
Spearman’s correlation with age is indicated. IFNγ, interferon gamma; 
IL10, interleukin 10; TNFα, tumor necrosis factor alpha.
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Figure S5A in Supplementary Material) or as a percent of total 
lymphocytes (p = 0.71, Figure S5B in Supplementary Material). 
This finding is consistent with the hypothesized trafficking of 
Pf-specific CD4 T cells to inflamed sites during active parasite 
infection (19, 20). The composition of the Pf-specific response 
was also investigated by calculating the proportion of each 
cytokine-producing combination among the total Pf-specific 
CD4 T-cell population. All subsets of CD4 T-cell responses 
were reduced during Pf infection; hence, there was no differ-
ence in the proportion of these subsets between infected and 
uninfected children after controlling for age (Figure S4B in 
Supplementary Material).
coproduction of il10 by Pf-specific iFnγ-
Producing cD4 T cells Declining with age
Several murine and human studies have suggested a role for 
T cells producing the canonical Th1 cytokines IFNγ and TNFα 
in clearance of parasite infection, whereas T-cell production of 
IL10, often in combination with IFNγ, has been postulated to 
prevent immunopathology at the expense of parasite clearance 
[reviewed in Ref. (3)]. To examine how production of these 
cytokines by Pf-specific CD4 T cells changes with age, we com-
pared children in three age strata (0–3, >3–7, and >7–11 years) 
spanning the age range during which clinical immunity to 
malaria typically emerges. We found no difference in the 
frequencies of total IFNγ-, IL10-, and TNFα-producing CD4 
T  cells across the different age strata (Figure  2A). However, 
when CD4 T-cell functional subsets were defined based on 
specific mono- or multifunctional subsets, several age-based 
trends became apparent. With increasing age, there was an 
increase in the frequency of Pf-specific CD4 T cells that pro-
duced IFNγ (with or without TNFα) but lacked IL10 produc-
tion (rho = 0.33, p = 0.001), whereas the frequency of IFNγ+/
IL10+ coproducing cells increased from 6 months to 3 years, 
and then declined (age < 3 rho = 0.41 p = 0.005 and age ≥ 3 
rho = –0.17, p = 0.01, Figure 2B). In parallel, among IFNγ-
producing CD4 T cells, the proportion that coproduced IL10 
declined across all ages, from 6 months to 10 years (rho = –0.29, 
p < 0.001, Figure 2C). These associations remained significant 
after accounting for current parasite infection and dMER 
(adjusted regression Coeff. –1.9, p =  0.001). There was no 
association between age and IL10 or TNFα monofunctional 
CD4 T cells.
il10 Production by cD4 T cells associated 
With recent high-Density Parasite 
infection
Because IFNγ/IL10 CD4 T-cell responses have been associ-
ated with high antigen burden in other systems (21, 22), we 
assessed the relationship of Pf–specific responses and parasite 
density during the most recent infection (within 3 months prior 
to blood draw). Among the 80% of children who had a parasite 
infection in the preceding 3 months (with or without symptoms), 
there was a highly significant positive correlation between the 
frequencies of Pf-specific total IL10 producing CD4 T  cells 
and parasite density during infection (rho = 0.35, p < 0.0001, 
Figure  3A). This relationship was seen with both IFNγ/
IL10 coproducing and IL10 monofunctional (IFNγ−/IL10+) 
FigUre 3 | Pf-specific IL10+ CD4 T cells associated with parasite density during last infection. For children with a documented plasmodial infection in the preceding 
3 months (n = 213), the association between the parasite density (parasites/μL) during the most recent infection and (a) the frequency of total Pf-specific IL10+ CD4 
T cells or (b) IFNγ+/IL10− cells are shown. IFNγ, interferon gamma; IL10, interleukin 10; Pf, Plasmodium falciparum.
FigUre 4 | IL10+ CD4 T cells expressing Tbet(hi) and BLIMP-1. (a) Representative plot showing expression of the transcription factors T-bet and BLIMP-1 on 
Pf-specific responses production IL10 (IL10+/IFN+/−/TNFα−) or TNFα (IL10−/IFN+/−/TNFα+) within one individual. Relative T-bet (b) and BLIMP-1 (c) expression on 
Pf-specific responses production IL10 (IL10+/IFN+/−/TNFα−) and TNFα (IL10−/IFN+/−/TNFα+). Shown are data from 15 independent individuals. gMFI, geometric mean 
fluorescence intensity; IFNγ, interferon; IL10, interleukin 10; TNFα, tumor necrosis factor alpha.
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(Spearman’s rho =  0.37 p <  0.0001 and rho =  0.2 p =  0.004, 
respectively). Parasite density was not associated with the fre-
quency of CD4 T cells producing IFNγ without IL10 (Figure 3B) 
or TNFα responses (monofunctional or in combination with 
IFNγ). The total IL10 response and frequency of IFNγ/IL10 
coproducing cells, but not IL10 single-producing cells, were 
weakly associated with malaria incidence in the preceding year 
(rho = 0.14, p = 0.02, rho = 0.16, p = 0.01 and rho = 0.026, 
p  =  0.67, respectively), consistent with prior reports (8). 
We did not observe any associations between household mos-
quito exposure (dMER) and IL10 production by Pf-specific 
CD4 T  cells. While younger children tended to have higher 
parasite densities (Figure S1B in Supplementary Material), age 
did not fully explain the relationship between IL10-producing 
cells and parasite density during recent infection, as the 
association with parasite density and total IL10 or IFNγ/IL10 
coproducing cells remained significant after controlling for age, 
dMER, and current infection (adjusted regression coefficient 
for total IL10 0.15, p < 0.001 and for IFNγ+/IL10+ cells 0.16, 
p < 0.001).
Pf-specific il10-Producing cD4 T cells 
expressing bliMP-1
We have previously shown that Pf-specific IFNγ/IL10 coproduc-
ing cells express the canonical Th1 transcription factor T-bet and 
are not FoxP3+ regulatory T cells (8). IL-10 in Th1 CD4 cells may 
be expressed in part to limit inflammation, at the cost of impaired 
pathogen clearance (23). Recent reports have also shown that 
the transcriptional regulator BLIMP-1 is required to program 
Th effectors into IL-10 producers in murine models of chronic 
infection (24, 25) [including Plasmodium (13)]. We assessed 
T-bet and BLIMP-1 expression among Pf-cytokine-producing 
cells (Figure 4A) and found that levels of T-bet were significantly 
higher on IL10 producing cells than on IFNγ or TNFα cells 
that did not produce IL10 (Figure 4B). Furthermore, BLIMP-1 
was highly expressed among Pf-specific IL10-producing CD4 
T  cells, but not on IFNγ or TNFα cells that did not produce 
IL10 (Figure 4C). Taken together, these data suggest that IL10 
production by Pf-specific CD4 T  cells is associated with high-
parasite antigen burden in children heavily exposed to malaria, 
is independently influenced by age, and may be induced through 
FigUre 5 | IL10 single-producing CD4 T cells associated with protection from symptomatic malaria. The associations between frequencies of Pf-specific total  
CD4 T cells producing IFNγ, IL10, TNFα, or specific subsets of responses (IFNγ+/IL10+, and IFNγ−/IL10+ with or without TNFα, and IL10+ and TNFα+ single-
producing CD4 T cells) with clinical outcomes in the year following blood draw were calculated by generalized estimate equations with robust SEs accounting for 
repeated measures within patients; (a) Odds ratios for associations with any infection (LAMP positive or blood smear positive). Data are univariate or adjusted for 
age, mosquito exposure (dMER), and bloodsmear and PCR positive infection at time of sampling, clustered on household. (b) Odds ratios for associations with 
probability of symptomatic malaria given patent infection (blood smear positive). Data are univariate, or adjusted for age and bloodsmear and PCR positive infection 
at blood draw. *p < 0.05. (c) The frequencies of Pf-specific IL10+ single-producing CD4 T and TNFα+ single-producing CD4 T cells between children who had at 
least one blood smear positive infection, who were always symptomatic when infected (n = 102), compared with those who were never symptomatic (n = 26) when 
infected in the year following blood draw p-values based on Wilcoxon rank sum test). IFNγ, interferon gamma; IL10, interleukin 10; Pf, Plasmodium falciparum; 
dMER, daily mosquito exposure rate; LAMP, loop-mediated isothermal amplification; PCR, polymerase chain reaction; TNFα, tumor necrosis factor alpha.
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expression of the transcriptional regulator BLIMP-1, as recently 
reported in murine models (13).
relationship of the cD4 T-cell  
response to Protection from  
Pf infection and clinical Malaria
Prospective Protection from Pf Infection
Mounting evidence suggests that the immune mechanisms 
underlying protection from Pf infection (or restriction of 
parasite growth) may be distinct from those that mediate 
“clinical immunity,” or protection from symptomatic malaria. 
To investigate the role of cytokine-producing CD4 T  cells in 
both aspects of naturally acquired immunity, we first analyzed 
the relationship between Pf-specific CD4 T-cell responses and 
protection from any Pf infection during 1  year of prospective 
follow-up. Subjects were assessed during routine quarterly visits 
for infection detected by blood smear (with or without symp-
toms) or by the sensitive LAMP assay (16). In univariate analysis, 
a higher total frequency or proportion of total TNFα-producing 
CD4 T cells was associated with a lower risk of infection (any 
infection, blood smear, or LAMP detected; p = 0.04 and 0.007, 
Figure 5A; Table S3 in Supplementary Material). However, after 
adjusting for age, dMER, and infection status at sampling (PCR 
and/or blood smear positive infection), these relationships were 
not significant (p =  0.55 and 0.26; Table S3 in Supplementary 
Material). In contrast, the proportion of cells producing IFNγ 
without IL10 was associated with a trend to increased prospec-
tive risk of infection in univariate analysis, but this was not 
significant following adjustment for dMER and other covariates 
(OR 1.01 for a 1% increase in IFNγ production in the absence of 
IL10, p = 0.06, Table S3 in Supplementary Material). There was 
no association between the frequency of total IFNγ, total IL10, 
nor other subsets of CD4 T-cell responses and prospective risk 
of infection (Figure 5A; Table S3 in Supplementary Material). 
In summary, among highly exposed children, all of whom 
had a measurable Pf-specific CD4 T-cell response, neither the 
frequency of these cells nor their cytokine production profiles 
correlated with prospective protection from infection after 
adjustment for household exposure intensity.
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Prospective Protection from Clinical Malaria  
Once Infected
Although not all infections result in symptomatic malaria and 
asymptomatic infections increase with age and prior exposure, 
we separately analyzed the conditional probability that an 
individual developed symptomatic malaria, given that s/he had 
a patent blood smear positive infection. After controlling for 
age and infection at time of sampling (PCR and/or blood smear 
positive infection), higher frequencies of Pf-specific monofunc-
tional IL10 CD4 T cells were associated with a decreased odds 
of symptoms, given patent infection (adjusted OR 0.66 95% 
CI 0.43–0.99, p = 0.05, Figure 5B; Table S4 in Supplementary 
Material. In contrast, the frequency of Pf-specific monofunc-
tional TNFα CD4 T cells was associated with an increased odds 
of developing symptomatic malaria, given patent Pf infection 
(OR 1.64 95% CI 1.08–2.49, p = 0.02, Figure 5B; Table S4 in 
Supplementary Material). Consistent with these findings, in 
the subsequent year, children whose patent infections were 
all asymptomatic had increased frequencies of Pf-specific 
monofunctional IL10 CD4 T  cells (p =  0.01) compared with 
children who always experienced malaria when infected (total 
children n = 128, analysis includes non-routine visits to study 
clinic) (Figure 5C). While there was also a trend to decreased 
frequencies of Pf-specific monofunctional TNFα CD4 T cells 
in children who always were asymptomatic when infected, this 
association was not statistically significant (p =  0.1). There 
was no association between the frequency of other functional 
subsets and the odds of symptoms given patent infection 
(Figure 5B).
DiscUssiOn
Prior studies in both humans and animal models support 
an important role for CD4 T  cells in mediating immunity to 
malaria [reviewed in Ref. (3)]. However, the factors influencing 
functional differentiation of Pf-specific CD4 T cells and the role 
of specific cytokine-producing subsets in protective immunity 
remain poorly understood. Here, in a large cohort of children 
aged 6 months to 10 years, we found that recurrent and/or high-
density Pf parasitemia was associated with an IL10-dominant CD4 
T-cell phenotype, particularly in younger children. Pf-specific 
IL10 production from CD4 T cells, specifically in the absence of 
IFNγ coproduction, was associated with a reduced likelihood of 
febrile malaria upon Pf infection. In contrast, our data suggest 
that monofunctional TNFα CD4 T cells may be associated with 
a higher likelihood of symptoms once infected.
Our data bolster the existing evidence that protection from 
Pf infection and protection from clinical malaria are medi-
ated by distinct immunological processes. In our cohort, the 
prospective risk of infection increased between 0 and 10 years 
of age as reported previously (26), possibly due to increasing 
body surface area (27), behavioral factors such as bed net usage 
(28) and/or treatment patterns due to increasing immunity. 
In contrast, the risk of symptomatic malaria and parasite den-
sity during infection declined over this age range. These obser-
vations are in agreement with those of Tran et al., who reported 
no difference in time-to-infection by age among seasonally 
exposed Malian adults and children (2). Taken together, these 
findings support the notion that the age-associated clinical 
immunity observed among residents of endemic regions does 
not confer sterile protection against Pf parasitemia. However, 
parasite density declined notably over this age interval, indi-
cating the emergence of an adaptive immune response capable 
of restricting parasite growth and limiting antigen burden. 
Identifying immune correlates of protection from Pf infection 
and clinical malaria in naturally exposed populations has 
been difficult for several reasons, including the challenge of 
accounting for heterogeneity in exposure to infected mosqui-
toes. Our cohort has the distinct advantage of having a rich 
longitudinal clinical dataset as well as measures of mosquito 
exposure both prior to and following the blood draw, enabling 
evaluation of both the determinants of the CD4 response and 
correlates of prospective protection from both parasitemia and 
clinical malaria.
Consistent with our prior observations, the majority of 
Pf-specific CD4 T  cells in heavily exposed Ugandan children 
produced the immunoregulatory cytokine IL10 (7–9). We show 
that CD4 IL10 production is associated with high-parasite 
antigen burden, consistent with other infections as well as non-
infectious disease models (21, 29). Secretion of IL10 by CD4 
T cells may attenuate pathogen-induced immunopathology by 
both directly inhibiting T-cell cytokine production and prolif-
eration, and limiting the function of antigen presenting cells. 
We and others have shown that this IL10 is produced largely 
by CD4 T  cells expressing the Th transcription factor Tbet, 
many of which coproduce IFNγ. Our prior data suggest that 
these cells appear consistent with “early effector memory” cell 
phenotype (CD45RA−, CCR7−, CD27+) (8), whereas Pf-specific 
CD4 T  cells producing inflammatory cytokines IL2 and 
TNFα are more consistent with “central memory” phenotypes 
(CD45RA−CCR7+) (7). Although IL-10 can be produced by a 
variety of CD4 T-cell subsets, IL-10 production by using the 
Th1 subset has been shown to be required for attenuation of 
morbidity and immune-mediated pathology during primary 
murine malaria infection (30, 31) and other protozoal infections 
(11, 12). Here we show that Pf-specific IL10-producing CD4 
T  cells in children express the transcription factor BLIMP-1, 
a transcriptional regulator recently shown to be critically 
dependent for IL-10 production from murine “TR1 cells” (13), 
further supporting the notion that IL10-producing Pf-specific 
CD4 T cells are Th1 origin. In contrast Pf-specific CD4 T cells 
producing TNFα do not express BLIMP-1 and express signifi-
cantly lower levels of Tbet.
In our cohort, it was specifically monofunctional IL10 CD4 
T cells that were associated with a reduced risk of symptomatic 
malaria following Pf infection; high frequencies of these cells 
were significantly associated with reduced odds of sympto-
matic malaria when infection. This is consistent with studies 
from children who are seasonally exposed to malaria, where 
IL-10 production following in vitro stimulation of PBMCs with 
malaria antigens was higher among children who persistently 
harbored parasites through the dry season, but not in children 
lacking recent parasite exposure (10). Furthermore, a recent 
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study indicated that patients with severe malaria had reduced 
proportions of IL10 single-producing CD4 T  cells compared 
with those with uncomplicated malaria, while the propor-
tions of IFNγ single-producing or IFNγ/IL10 coproducing 
CD4 T  cells were similar between disease phenotypes (32). 
In vitro stimulation studies have shown that Th1 IFNγ CD4 
T cells can switch to IFNγ/IL10 coproducing, and then to IL10 
single-producing CD4 T cells with repeated stimulation (33). 
In our cohort, both IFNγ/IL10 coproducing and IL10 single-
producing subsets were associated parasite density during 
recent infection, while only IL10 single-producing responses 
were associated with protection from symptomatic disease. 
Together, these data suggest that a final switch from IFNγ to 
IL10 production among malaria-specific CD4+ T  cells may 
play a role for in mediating tolerance to malaria. Importantly, 
exploitation of this pathway has recently been shown to be 
effective as antigen-specific immunotherapy for autoimmune 
disease (34).
Our data also indicate that biological age influences CD4 
T-cell production of IL10 independently of antigen burden, 
with younger children biased toward a more IL10-skewed 
CD4 T-cell response, suggesting an inherent age-related 
developmental difference in the cellular immune response 
(35). In areas of high malaria transmission, untangling the 
influence of age and exposure on the immune response is 
complicated by the colinearity of age and cumulative parasite 
exposure. Here we used detailed clinical and entomological 
data to show that age and exposure independently influence 
the Pf-specific CD4 T-cell response. Innate immune responses 
to T-like receptor stimulation are dominated by regulatory 
cytokines including IL10 in early life, and the production of 
cytokines that support Th1 CD4 T-cell development are one 
of the last to reach adult levels (36–38). This regulatory bias 
in early life may in part help to explain observations made 
among Indonesian migrants moving from areas with little or 
no malaria to high-transmission regions where young children 
with their first malaria infection were far less susceptible to 
severe malaria and death than adults, but adults developed 
immunity to mild malaria more rapidly than children (39–42). 
Despite the age-associated decline in IL10 production, even 
the oldest children in our cohort exhibited higher frequencies 
of IL10 CD4 T cells and lower frequencies of TNFα production 
by CD4 T cells than adults at the same study site (9), which 
may be related to continued immune maturation and/or to the 
much lower rates of patent Pf parasitemia among adults in this 
cohort (26).
Our data suggest that in contrast to IL10, Pf-specific mono-
functional CD4 cells producing TNFα may be associated with a 
higher risk of clinical disease once infected. While the strength 
and significance of this relationship was less clear in the current 
study, it is supported by our previous finding that prevalence of 
asymptomatic parasite infection was reduced in 4-year-old chil-
dren with high frequencies of Pf-specific TNFα-monofunctional 
CD4 T cells (8). In the present cohort, TNFα-producing CD4 
cells were also associated with protection from infection in 
univariate analysis, but this association was not significant after 
controlling for exposure intensity and age. This result suggests 
that TNFα production from CD4 T cells may be associated with 
low parasite exposure, highlighting the importance of account-
ing for heterogeneous exposure to Pf-infected mosquitoes in 
cohort studies examining correlates of prospective infection 
risk. Together our findings underscore the delicate balance of 
CD4 T-cell responses required to mediate protection from infec-
tion and disease. We did not find any associations between CD4 
production of IFNγ and protection from malaria, consistent 
with our previous studies in this high-transmission setting (7, 8). 
This is in contrast to previous reports finding such associa-
tions when looking at IFNγ responses via methods that assess 
total cytokine from PBMCs (4). These differing results reflect 
important differences between the use of multi-parametric flow 
cytometer to assess individual subsets of CD4 T-cell responses 
verses methods that evaluate global assessments of cytokine 
production which are unable to distinguish between IFNγ from 
CD4 T  cells, with that from other sources—for example from 
γδ T cells where IFNγ production may have a differing role in 
protection and disease (43–45).
This study has several limitations inherent in its cross-
sectional sampling of individuals, including the inability to 
assess the functional differentiation of CD4 T-cell responses 
within individuals across time. In addition, we measured 
CD4 production of only three cytokines, but other CD4 
cytokine-producing phenotypes may also be important (7, 46). 
Furthermore, although we observed significant heterogeneity 
in environmental exposure to Pf based on entomological 
measures, the vast majority of cohort participants had very 
high levels of exposure intensity, such that even children with 
the lowest levels of exposure in this study cohort had very high 
exposure relative to most malaria-endemic communities. In a 
study comparing children and adults from the current study 
site to those in a nearby low-transmission site, we have previ-
ously shown that exposure strongly influences the functional 
phenotype of Pf-specific CD4 T-cell responses (9). We did not 
observe marked differences based on exposure intensity in the 
current study, perhaps due to “saturated” mosquito exposure. 
Hence, our findings may not be applicable to other settings 
with lower transmission intensity. Lastly, while adjustment 
for entomological exposure helped to limit confounding by 
exposure intensity, it is possible that associations between 
Pf–specific CD4 T-cell profiles and prospective clinical out-
comes may be driven by the impact of antigen burden on CD4 
functional phenotype, rather than CD4-mediated immune 
protection.
In conclusion, in a large cohort of naturally exposed children, 
we have identified factors influencing the cytokine production 
profiles of Pf-specific CD4 T cells, with both exposure and age 
being independently associated with IL10 CD4 T-cell responses. 
Monofunctional IL10 CD4 T  cells were associated with high 
antigen burden and/or repeated infections, and were associated 
with protection from symptoms once infected. These findings 
elucidate important factors that influence the development of 
Pf -specific CD4 T cells and their roles in human immunity to 
malaria.
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